April 10, 2018
eviCore Online Enhancements to Improve Clinical Consultations
eviCore understands that the consultation process takes valuable time away from your patients. After reviewing feedback they’ve received, eviCore has developed educational materials to help you during the consultation scheduling process.
View Full Post
February 27, 2018
Principal or Primary Diagnosis for Chemotherapy Administration
According to the ICD Manual guidelines, encounter for antineoplastic chemotherapy (ICD-10 code Z51.11) or encounter for antineoplastic immunotherapy (ICD-10 code Z51.12) must be the principal or primary diagnosis, followed by the diagnosis of the current acute disease or injury for chemotherapy administration (96401-96450, 96542-96549).
View Full Post
February 20, 2018
Dr. Kristine Carpenter, a Carle family medicine OB-GYN in Mattoon, IL, boasts high numbers when it comes to chlamydia screening rates. While the subject matter is sometimes tricky to approach, there is nothing tricky about her approach at all.
View Full Post
February 14, 2018
There’s a new blood glucose-monitoring device, called Freestyle Libre, which uses sensor needle pads for continuous glucose readings instead of frequent finger sticks.
View Full Post
February 13, 2018
Utilization Review Determinations
As you all know, in 2017 we entered into a partnership with eviCore for managing certain preauthorization and utilization management requests. Some providers may be communicating to patients that eviCore is making coverage decisions.
View Full Post